University Of Melbourne
Clinical trials sponsored by University Of Melbourne, explained in plain language.
-
Could a second drug boost stroke recovery?
Disease control Recruiting nowThis study tests whether giving a clot-busting drug called tenecteplase directly into the brain artery after mechanical clot removal helps people recover better from a severe stroke. About 462 adults with a large vessel blockage in the front part of the brain will be randomly ass…
Phase: PHASE2, PHASE3 • Sponsor: University of Melbourne • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Brace vs. surgery: can a simple knee brace heal a torn ACL?
Disease control Recruiting nowThis study compares two ways to treat a torn anterior cruciate ligament (ACL): a new bracing protocol (wearing a knee brace for 12 weeks plus physiotherapy) versus early surgery. 180 people aged 16-40 with a recent ACL tear will be randomly assigned to one of the two groups. Rese…
Phase: NA • Sponsor: University of Melbourne • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug could extend window for treating deadly stroke
Disease control Recruiting nowThis trial is testing a drug called tenecteplase for people with a severe stroke caused by a blockage in the basilar artery at the back of the brain. About 688 participants will receive either tenecteplase or standard care within 24 hours of symptoms starting, followed by a clot-…
Phase: PHASE2, PHASE3 • Sponsor: University of Melbourne • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
8,000-Patient trial aims to find best way to beat deadly staph blood infection
Disease control Recruiting nowThis massive international trial is testing several antibiotics and treatment strategies to find the best way to reduce deaths from Staphylococcus aureus bloodstream infections. About 8,000 hospitalized adults with a confirmed staph blood infection will be randomly assigned to di…
Phase: PHASE4 • Sponsor: University of Melbourne • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a cancer drug help flush out hidden HIV?
Disease control Recruiting nowThis study is testing whether a single low dose of nivolumab, a drug used in cancer immunotherapy, can reduce the latent HIV reservoir in people living with HIV who are on antiretroviral therapy (ART). The latent reservoir is a group of dormant HIV-infected cells that current tre…
Phase: PHASE1, PHASE2 • Sponsor: University of Melbourne • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New brain bleed surgery could save lives and reduce disability
Disease control Recruiting nowThis trial tests a new, less invasive surgery to remove blood clots from the brain after a severe stroke caused by bleeding. The surgery is done within 8 hours of symptoms starting. About 240 adults with large brain bleeds will be randomly assigned to either this surgery or stand…
Phase: NA • Sponsor: University of Melbourne • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Pre-surgery 'school' via video may cut complications after cancer surgery
Symptom relief Recruiting nowThis study tests whether a telehealth education program, called Surgery School, helps people prepare for lung or major abdominal cancer surgery. Participants will watch videos and talk with a clinician online before their operation. The goal is to see if this reduces breathing pr…
Phase: NA • Sponsor: University of Melbourne • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Diet or therapy? new study aims to find the best online treatment for IBS
Symptom relief Recruiting nowThis study compares two online treatments for Irritable Bowel Syndrome (IBS): a low-FODMAP diet program and exposure-based cognitive behavioral therapy (E-CBT). Researchers want to find out which treatment works best for different people and how they work. The study will include …
Phase: NA • Sponsor: University of Melbourne • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
530 hay fever volunteers needed to stop thunderstorm asthma attacks
Knowledge-focused Recruiting nowThis study is looking for 530 adults with hay fever in South-Eastern Australia to help create a tool that predicts thunderstorm asthma. Participants will have allergy and lung function tests, then track their symptoms during spring for two years. The goal is to find warning signs…
Phase: NA • Sponsor: University of Melbourne • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC